SCHEMBL5073333

SCHEMBL5073333

CN(C(=O)O)C1CCN(C2CNC2)CC1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 5/20 0.34
L3MBTL3 Q96JM7 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DRD2 P14416 2/20 0.32
HTR2A P28223 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
SIGMAR1 Q99720 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
KCNH2 Q12809 2/20 0.31
HTR6 P50406 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30
BRD4 O60885 1/20 0.30
TAF1 P21675 1/20 0.30
CECR2 Q9BXF3 1/20 0.30
BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16633564 0.79 CCR5 (0.32) CCR5MEN1ALDH1A1KMT2A
SCHEMBL16822461 0.77 L3MBTL3 (0.38) L3MBTL3L3MBTL1HTR6
SCHEMBL16365471 0.76 HTR6 (0.39) L3MBTL3L3MBTL1KCNH2HTR6
SCHEMBL3278591 0.75 L3MBTL3 (0.44) L3MBTL3L3MBTL1ALDH1A1KDM4E
SCHEMBL3278589 0.75 L3MBTL3 (0.44) L3MBTL3L3MBTL1ALDH1A1KDM4E
SCHEMBL1221378 0.75
SCHEMBL493685 0.74 DPP4 (0.40) MEN1KMT2ABCHE
SCHEMBL8282498 0.74 ALDH1A1 (0.45) L3MBTL1HTR2AHTR2CALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL5901388 0.73
SCHEMBL7278291 0.73 BCHE (0.57) ALDH1A1KDM4EBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899318-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AstraZeneca AB (SE) 2008-03-19 EP disclosed
WO-2006137791-A1 NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES ASTRAZENECA AB (SE) 2006-12-28 WO disclosed